Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517971 · ClinicalTrials.gov registry record
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
A clinical trial of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 1,060
- Enrollment target
- 1
- Study location
NCT01517971 is a study of Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,060 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01517971, a study of Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 1,060 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial studies biomarkers in predicting the risk of cancer returning after surgery in tissue samples of patients with early-stage non-small cell lung cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer and predict how well patients will respond to treatment.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2012-01 |
| Est. Completion | 2019-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01517971
The ClinicalTrials.gov registry entry for NCT01517971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,060 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (14% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01517971 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01517971 about?
NCT01517971 is a clinical study titled "Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer". This research trial studies biomarkers in predicting the risk of cancer returning after surgery in tissue samples of patients with early-stage non-small cell lung cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about bioma...
What is the current status of trial NCT01517971?
This trial is currently completed. The enrollment target is 1,060 participants. The study started on 2012-01. Estimated completion is 2019-02-27.
What conditions does trial NCT01517971 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01517971?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01517971?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01517971 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.